BA
Baroda BNP Paribas Innovation Fund Direct Growth
Latest NAV
+9.02% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty 500 TRI
Expense ratio
1.04%
AUM
₹918 Cr
Min SIP
₹500
Min lump sum
₹1,000
1Y
+9.02%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Mar 2024
Where the NAV sits & how risky it is
₹13.63
52-week range
at 69%
₹13.63
Low 23 Mar 2026₹11.68
High 31 Aug 2026₹14.52
Risk level
Very High
Low
Very high
NAV history
07 Mar 2024
Since inception
01 Oct 2026
Returns by period
1W
-3.04%
1M
-4.89%
3M
-0.35%
6M
+14.22%
1Y
+9.02%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹500
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 93.05%
Cash & other 6.95%
Sector split
Country split
Top 5 hold 20.8%
Top 10 hold 35.3%
54 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Linde
INE473A01011 |
Basic Materials Specialty Chemicals |
India |
4.56%
|
+17.90% |
| 2 | Hitachi Energy
INE07Y701011 |
Industrials Electrical Equipment & Parts |
India |
4.40%
|
+85.50% |
| 3 | MCX
INE745G01043 |
Financial Services Financial Data & Stock Exchanges |
India |
4.06%
|
+27.14% |
| 4 | One 97 Communications
INE982J01020 |
Technology Software - Infrastructure |
India |
3.91%
|
-13.40% |
| 5 | Acutaas Chemicals
INE00FF01025 |
Basic Materials Specialty Chemicals |
India |
3.89%
|
+93.61% |
| 6 | Navin Fluorine International
INE048G01026 |
Basic Materials Chemicals |
India |
3.22%
|
+28.68% |
| 7 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.05%
|
+5.02% |
| 8 | Bharti Airtel
INE397D01024 |
Communication Services Telecom Services |
India |
2.79%
|
-12.11% |
| 9 | TVS Motors
INE494B01023 |
Consumer Cyclical Auto Manufacturers |
India |
2.74%
|
-3.71% |
| 10 | Lenskart Solutions
INE956O01016 |
Healthcare Medical Instruments & Supplies |
India |
2.70%
|
+12.91% |
About this scheme
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of companies focusing and benefitting from innovation. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
Fund manager(s): Jitendra Sriram, Abhay Joshi
Exit load: Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
07 Mar 2024
Lump-sum min
₹1,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 112.5 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 24.4 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 21.6 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 21.6 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 20.2 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 20.1 pts ahead of this fund